lu 135252 has been researched along with Hypertrophy in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (28.57) | 18.2507 |
| 2000's | 5 (71.43) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bauer, C; Hocher, B; Neumayer, HH; Priem, F; Raschak, M; Trenkner, J | 1 |
| Amann, K; El-Shakmak, A; Gross, ML; Koch, A; Kuhlmann, A; Münter, K; Ritz, E; Szábó, A | 1 |
| Amann, K; Banas, B; Orth, SR; Ritz, E; Schiele, G | 1 |
| Barton, M; d'Uscio, LV; Lüscher, TF; Moreau, P; Shaw, S; Takase, H | 1 |
| Barton, M; d'Uscio, LV; Lüscher, TF; Meyer, P; Moreau, P; Shaw, S | 1 |
| Barton, M; Boer, P; D'Uscio, LV; Gröne, HJ; Lattmann, T; Lüscher, TF; Moreau, P; Rabelink, TJ; Shaw, S; Vos, I | 1 |
| Cernacek, P; Dao, HH; de Champlain, J; Larivière, R; Martens, FM; Moreau, P; Yamaguchi, N | 1 |
7 other study(ies) available for lu 135252 and Hypertrophy
| Article | Year |
|---|---|
Endothelin receptor A blockade reduces proteinuria and vascular hypertrophy in spontaneously hypertensive rats on high-salt diet in a blood-pressure-independent manner.
Topics: Animals; Dose-Response Relationship, Drug; Endothelin Receptor Antagonists; Hypertension; Hypertrophy; Kidney Failure, Chronic; Phenylpropionates; Proteinuria; Pyrimidines; Rats; Rats, Inbred SHR; Receptor, Endothelin A; Renal Circulation; Sodium Chloride, Dietary | 2002 |
ACE-inhibitors but not endothelin receptor blockers prevent podocyte loss in early diabetic nephropathy.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Disease Models, Animal; Endothelin Receptor Antagonists; Hypertrophy; Kidney Glomerulus; Kidney Tubules; Male; Phenylpropionates; Pyrimidines; Rats; Rats, Sprague-Dawley | 2003 |
Effect of a selective endothelin receptor A blocker on cardiovascular remodeling in uninephrectomized spontaneously hypertensive rats of the stroke-prone strain.
Topics: Animals; Aorta, Thoracic; Arterioles; Blood Pressure; Body Weight; Cardiovascular System; Disease Models, Animal; Endothelin A Receptor Antagonists; Genetic Predisposition to Disease; Hypertrophy; Male; Nephrectomy; Phenylpropionates; Pyrimidines; Rats; Rats, Inbred SHR; Stroke; Tunica Media; Ventricular Remodeling | 2007 |
Angiotensin II increases tissue endothelin and induces vascular hypertrophy: reversal by ET(A)-receptor antagonist.
Topics: Angiotensin II; Animals; Arteries; Basilar Artery; Blood Pressure; Endothelin Receptor Antagonists; Endothelins; Hypertrophy; Mesenteric Arteries; Phenylpropionates; Pyrimidines; Rats; Rats, Inbred WKY; Receptor, Endothelin A | 1997 |
ET(A) receptor blockade prevents increased tissue endothelin-1, vascular hypertrophy, and endothelial dysfunction in salt-sensitive hypertension.
Topics: Acetylcholine; Animals; Aorta, Thoracic; Blood Pressure; Endothelin Receptor Antagonists; Endothelin-1; Endothelium, Vascular; Hypertension; Hypertrophy; In Vitro Techniques; Male; Muscle Contraction; Muscle, Smooth, Vascular; Nitroprusside; Phenylpropionates; Potassium Chloride; Pyrimidines; Rats; Rats, Inbred Strains; Receptor, Endothelin A; Sodium, Dietary; Systole; Vasodilation | 1998 |
Dysfunctional renal nitric oxide synthase as a determinant of salt-sensitive hypertension: mechanisms of renal artery endothelial dysfunction and role of endothelin for vascular hypertrophy and Glomerulosclerosis.
Topics: Acetylcholine; Animals; Endothelin Receptor Antagonists; Endothelin-1; Endothelium, Vascular; Enzyme Inhibitors; Glomerulosclerosis, Focal Segmental; Hypertension; Hypertrophy; Kidney; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Phenylpropionates; Pyrimidines; Rats; Rats, Inbred Dahl; Renal Artery; Sodium Chloride, Dietary; Vasodilator Agents | 2000 |
Transient involvement of endothelin in hypertrophic remodeling of small arteries.
Topics: Angiotensin II; Animals; Endothelin Receptor Antagonists; Endothelin-1; Endothelins; Hypertrophy; Mesenteric Arteries; Norepinephrine; Phenylpropionates; Pyrimidines; Rats; Rats, Sprague-Dawley; Time Factors; Vascular Resistance | 2001 |